
MSM May Underestimate HIV Risk
New study findings suggest that more at-risk individuals should take pre-exposure prophylaxis to prevent HIV.
Although researchers continue to make great strides in the fight against HIV, there are still many obstacles to overcome in terms of prevention. One such obstacle is accurate HIV risk perception among men who have sex with men (MSM), a population that accounts for
In an oral abstract session at the
To address this issue, Dr. Blumenthal and her team studied whether or not providing information on their risk of contracting HIV to MSM would increase their uptake of PrEP. The team tested this hypothesis in a randomized controlled trial dubbed, PrEP Accessibility Research and Evaluation 2, or PrEPARE2, which enrolled 171 MSM participants, all recruited from HIV testing sites.
For more information, please visit
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.